Mapol Inc. will be hosting the 9th Annual Education and Training Seminar in Toronto/Brampton on Wednesday May 1, 2019 and Montreal on Friday May 3, 2019. This will be an opportunity for you to hear from key stakeholders about new developments being implemented and/or considered for private drug plans. Also, Mapol will be highlighting key trends and issues for 2019. 

Confirmed Stakeholder Speakers for Both Full-Day Sessions Include:

• Dr. Luc Boileau, M.D., M. Sc. Adm. S., FRCPC, President and CEO, INESSS, Update on INESSS - 2019 and Beyond (MONTREAL ONLY)
• WEBINAR: TELUS Health Enhanced Drug Review Process, Overview of the Requirements and Procedures for the TELUS Health Enhanced Drug Review Process
• Tim Clarke, BMath FSA FCIA, President, tc Health Consulting,Pharma and Digital Health – Evolving Fast, But Can Benefit Plans Keep Up?
• Neil Donald, Healthcare Industry Executive Specializing in Private Payer and Pharmacy Synergies, Exploring Private Payer Reimbursement Models Tied to Pharmacy Performance and Patient Outcomes
• Joan Weir, Director, Health And Disability Policy, Canadian Life and Health Insurance Association Inc. (CLHIA), OHIP+ Changes and Transition Process Considerations
• Suzanne Nagy, Drug Consulting Lead, Mercer Canada, Drug Plan Modernization: Optional Drug Coverage For Traditional “Lifestyle” Issues
• Johnny Ma, President and COO, Mapol Inc., Review of 2018 and 2019 Trends And Issues

EVENT FEE: $999.00 + HST per person. 

REGISTER FOR TORONTO                         REGISTER FOR MONTRÉAL
TORONTO – WEDNESDAY MAY 1, 2019                   MONTRÉAL – FRIDAY MAY 3, 2019
Hilton Garden Inn Toronto/Brampton                       Marriott Montréal Airport In-Terminal Hotel
2648 Steeles Avenue East                                          800 Place Leigh Capreol
Brampton, ON, L6S 6J9                                              Dorval, QC, H4Y 0A4
(905) 595-5151                                                             (514) 636-6700
Map and Directions                                                    Map and Directions  

GROUP DISCOUNT SPECIAL: Register three or more attendees and receive 20% off *. That's a savings of $199.80 + HST per registration. Please do not register on the registration pages and contact Sue-Lee Pring (spring@mapol.ca) for special group registration. 

*Terms for the Group Discount: 
     - All Attendees must be from the same organization
     - Attendees can attend either locations
     - Payment must be made on one credit card via PayPal
     - Offer ends on Friday April 19, 2019  

These are closed-door seminars for innovative pharmaceutical manufacturers. Given that this event has become very popular, we encourage you to register your spot as soon as possible because seating is limited. 

Medical Cannabis: Equal Access for All?
Session Date: Tuesday, April 17, 2018 07:30 to 08:30
Breakfast Session 5, Ballroom Level, Room 501/502

Panelists:
• Johnny Ma, Mapol Inc.
• Philippe Lucas, Tilray (Moderator)
• Dr. Bruno Battistini, New Brunswick Health Research Foundation
• Jonathan Zaid, Canadians for Fair Access to Medical Marijuana

The Canadian landscape for medical cannabis is quickly evolving, with a rapid increase in credible clinical evidence for its utilization for different medical conditions. There is increased awareness and demand from Canadian patients for timely, accessible, and affordable medical cannabis for appropriate use, but multiple barriers continue to exist, including suboptimal coverage by public and private payer plans. The objectives of this panel discussion will be the following:

• To present evidence on the appropriateness, effectiveness, and accessibility of medical cannabis for Canadians with medical conditions.
• To present the real-world findings of an evaluative framework used by Canadian payers for the timely and appropriate access to medical cannabis.
• To hear the patient voice on how improving reimbursement of medical cannabis improves appropriate, accessible, and affordable patient care, which can reduce reliance on other prescription drugs.
  
  

Mapol Inc. is proud to be a Platinum Sponsor at the 2018 CADTH Symposium in Halifax, N.S. April 16-17, 2018.

Download the 2018 Program for the CADTH Symposium.  

Poster Presentation: A Review of CDR Recommendations for Manufacturer Resubmissions

 On December 5th, Mapol hosted the 4th Annual Benefits Advisors’ Drug Plan Outlook in Toronto. This event brought together industry thought leaders from the benefits advisor and innovative pharmaceutical manufacturer communities from across Canada. With a shared objective of improving the plan sponsor and plan member experience with drug benefit coverage, there was agreement that more work is needed in 2018 to minimize the potential consequences resulting from legacy administrative practices or drug plan changes.

Key takeaways included the need for greater transparency in the premium setting process and the avoidance of unilateral contract changes with little choice for plan sponsors. To support employee health, there was an expressed need to allow plan members to stay on existing treatments without being forced to switch to different drugs as a result of changes to plan designs and/or transfers of contracts from one insurer to another. Participants at the meeting also felt that insurers can be active partners in the delivery and support of disease information to plan members and their dependents.

The proceedings of this event will be published in an upcoming edition of Benefits and Pensions Monitor.